Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Clinical Trial of Hydroxyflutamide (Liproca Depot) in localized Prostate Cancer within the intermediate risk group

Next Previous
Trial Profile

A Phase III Clinical Trial of Hydroxyflutamide (Liproca Depot) in localized Prostate Cancer within the intermediate risk group

Status: Suspended
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hydroxyflutamide (Primary)
  • Indications Prostate cancer
  • Focus Registrational; Therapeutic Use

    • Most Recent Events

    • 22 Feb 2024 Status changed to suspended, according to a LIDDS media release.
    • 22 Feb 2024 According to a LIDDS media release, company decided to halt all clinical development in order to significantly strengthen the company's financial sustainability as additional funding was not considered possible to obtain in the weak market environment. The measures will have full effect from the beginning of 2024.
    • 22 Nov 2021 According to a LIDDS media release, the company submitted the study protocol to the European Medicines Agency (EMA) for Scientific Advise (SA) on Sep 27, 2021.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top